Mitogen-activated protein kinase kinase 1 (MKK1), a dual-specificity tyrosine/threonine protein kinase, has been shown to be phosphorylated and activated by the raf oncogene product as part of the mitogen-activated protein kinase cascade. Here we report the phosphorylation and inactivation of MKK1 by phosphorylation on threonine 286 and threonine 292. MKK1 contains a consensus phosphorylation site for p34cdc2, a serine/ threonine protein kinase that regulates the cell division cycle, at Thr-286 and a related site at Thr-292. p34cdc2 catalyzes the in vitro phosphorylation of MKK1 on both of these threonine residues and inactivates MKK1 enzymatic activity. Both sites are phosphorylated in vivo as well. The data presented in this report provide evidence that MKK1 is negatively regulated by threonine phosphorylation.
The regulation of mammalian cell growth is accomplished by the integration of extracellular signals, such as polypeptide growth factors, with intracellular phosphorylation cascades extending from the plasma membrane to the cell nucleus. Recent studies have indicated that mitogen-activated protein (MAP) kinases (33, 41) , also known as extracellular signalregulated kinases (7) , are central to these intracellular signal transduction pathways. Two MAP kinases, p42maPk and p44mapk, have been well characterized in many mammalian cell systems (33, 41) . Both enzymes are phosphorylated on tyrosine and threonine and are activated by a novel protein kinase termed MAP kinase kinase (MKK), also known as MAP kinase/extracellular signal-regulated kinase (MEK) kinase (9, 15, 29, 34, 37) . The activity of MKK is specific for the regulatory residues, threonine 183 and tyrosine 185, in p42maPk (32) , suggesting that MKK is a key regulator of MAP kinases in the cell.
The regulation of the MKK/MAP kinase pathway is evolving as a network of crosstalking protein kinases and phosphatases that exert both positive and negative signals. For example, the cellular proto-oncogene product, c-Raf-1, catalyzes the phosphorylation and activation of MKK (10, 11, 23) . Furthermore, the effects of other upstream protein kinases on MKK activity are also becoming apparent. Several groups have demonstrated a link between the MKK pathway and cyclic AMPdependent protein kinase (3, 8, 17, 39, 43) . The latter protein kinase is thought to negatively regulate the protein kinase activity of c-Raf-1 (43) , thus preventing further activation of the MKK/MAP kinase pathway.
In addition to upstream negative regulation by protein phosphorylation, negative control of the MKK pathway also occurs at the MAP kinase level by dephosphorylation. A MAP kinase-specific phosphatase that specifically removes both types of regulatory phosphorylation has been documented (4) . MKK may also be subject to negative regulation by phosphatase action; treatment of active MKK protein kinase activity (9, 15, 29, 34, 36) . Although this method of inactivation has not been documented in vivo, observations suggest that additional phosphorylation(s) of MKK occurs following its initial activation and leads to increased susceptibility to inactivation by phosphatase 2A in vitro (1) . Taken together, these observations demonstrate that both protein kinases and phosphatases act upon MKK directly or indirectly after its initial phosphorylation and activation to rigorously control the activity of the MKK/MAP kinase pathway.
Recently, two isoforms of MKK, known as MKK1 and MKK2, were identified, and their amino acid sequences were elucidated (9, 31, 38, 45) . MKK1 contains a consensus sequence for phosphorylation by p34cdc2, a key regulator of the cell division cycle (5, 30) , at Thr-286, as well as another, related site at Thr-292. Active p34cdc2 kinase is a proline-directed protein kinase that preferentially catalyzes the phosphorylation of serine or threonine in the sequence S/TP(X)nZ, where n = 1 to 3 and Z is often lysine or arginine (28) . Thr-286 and Thr-292 are located within a large proline-rich insert in MKK1, near the substrate binding domain (between domains IX and X), suggesting a possible regulatory role for these potential phosphorylation sites. Although MKK1 and MKK2 are highly homologous, several important differences exist between these enzymes: the amino acid at position 286 in MKK1 is valine in MKK2, and the residue at position 292 in MKK1 is proline in MKK2. On the basis of these observations, we evaluated the potential regulation of mammalian MKK1 by p34cdc2 by testing its ability to phosphorylate MKK1 and to modify its enzymatic activity.
MATERIALS AND METHODS
Cell culture. HeLa cells were grown in suspension as previously described (27) . HeLa were incubated together at 30°C for 12 min prior to the addition of K52R. All reaction mixtures were then incubated at 30°C for 12 min, the reactions were stopped by the addition of sodium dodecyl sulfate (SDS) sample buffer (24) , and the mixtures were subjected to electrophoresis on a 10% (wt/vol) polyacrylamide gel in the presence of SDS. The gel was stained with Coomassie blue and dried, and the labeled proteins were visualized by autoradiography for 3.5 h at -70°C.
Peptide synthesis. The MKK1 peptide, corresponding to murine MKK1 residues 277 through 300, was synthesized on an ABI (Foster City, Calif.) 430A peptide synthesizer and purified by reverse-phase high-pressure liquid chromatography (HPLC), and the molecular weight was verified by mass spectral analysis on a mass spectrometer from Bio-Ion Inc. (Uppsala, Sweden).
Phosphopeptide mapping and sequencing. High-voltage electrophoresis-thin-layer chromatography (HVE/TLC) was performed as previously described (12) . In all cases, electrophoresis was along the horizontal axis and ascending hydrophobic chromatography was along the vertical axis with respect to the origin. Each phosphorylated peptide was scraped off the cellulose plate, eluted with pH 1.9 electrophoresis buffer (12), covalently attached to an aryl amine-derivatized membrane (Millipore, Bedford, Mass.), and subjected to repetitive cycles of Edman degradation as described previously (12, 35) .
For phosphopeptide sequencing, the MKK1 peptide (350 ,uM) was phosphorylated by p34cdc2 under the kinase assay conditions described above and purified from the kinase reagents by reverse-phase HPLC. The phosphorylated peptide was left undigested or digested for 4 h with 10 ,ug of trypsin (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) at 37°C and then incubated with an additional 10 ,ug of trypsin overnight at the same temperature. Both samples were subjected to HVE/TLC and repetitive Edman sequencing.
For phosphopeptide map comparisons, each sample was phosphorylated as described above or isolated from 32p_
labeled HeLa cells by immunoprecipitation, digested with 10 ,ug of thermolysin (Boehringer) in 50 mM ammonium bicarbonate, incubated at 37°C for 4 h, and subjected to HVE/TLC.
Immunoblotting and immunoprecipitation. An MKK1 peptide antibody (R1) was generated in rabbits against the synthetic peptide described above. Affinity-purified antibodies were isolated on an MKK1 peptide column and shown to be specific for MKK1 by immunoblotting and immunoprecipitating baculovirus-expressed MKK1 (data not shown). Antiserum specific for p34cdc (G6) was generated in rabbits a ainst the peptide carboxy terminus (11) 5) ; it corresponded to the p34cdc2-associated p62 cyclin that is phosphorylated by p34cdc2 (2, 11, 27) .
Inactivation of MKK1 by p34cdc2. To evaluate the effects of p34cdc2 on MKK1 function, it was necessary to include a specific substrate for MKK, namely, p42mpPk. However, wildtype p42maPk has been shown to be autophosphorylated on tyrosine (36, 46) . To avoid any interference by autophosphorylation, a mutant of p42maP (K52R) that is defective for protein kinase activity (25, 34) was used as a substrate to measure MKK1 activity (Fig. 1, lane 3 (Fig. 2) . Furthermore, heat inactivation of p34cdc2 prior to its addition to the kinase reaction failed to inhibit the phosphorylation of K52R by MKK1. This result argues that the observed inactivation of MKK1 is enzymatic and is not caused by a contaminant within the p34cdc2 preparation. Small amounts of CDC25, a tyrosine/threonine phosphatase, have been documented to be complexed with p34C c%yclin (14); therefore, this or other phosphatases could be responsible for the observed MKK1 inactivation. To address this issue, various phosphatase inhibitors were included in the MKK1 inactivation assay. The addition of the phosphatase inhibitors 1 mM sodium vanadate, 4 mM p-nitrophenyl phosphate, and 1 ,uM okadaic acid to the reaction mixtures failed to prevent MKK1 inactivation (data not shown). These results demonstrate that the inactivation of MKK1 is not attributable to the removal of the activating phosphate by a contaminating phosphatase within the p34 c preparation.
p34dc2 does not inactivate MKK2. Recently, the cloning and sequencing of rat MKK2 were reported (44) . MKK1 and MKK2 are highly conserved throughout most of their amino acid sequences but diverge significantly near the amino terminus and between kinase domains IX and X (Fig. 3A) , the region containing Thr-286 and Thr-292 in MKK1. Since both threonines are absent in MKK2 and both represent potential p34cdc2 phosphorylation sites on MKK1, we used baculovirusexpressed MKK2 (preactivated with v-Raf and purified) containing a 12-residue histidine tag at the amino terminus to evaluate the ability of p34cdc2 to catalyze the in vitro phosphorylation and inactivation of MKK2. Representative kinase assays with K52R or histone Hi as a substrate are graphically presented in Fig. 3B phosphorylation of the synthetic peptide by p34cdc2, and only phosphothreonine was detected (data not shown). To determine the site of phosphorylation, the phosphorylated peptide was subjected to two-dimensional HVE/TLC (Fig. 4A, inset) , elution, and repetitive Edman degradation. Phosphate release from the sequencer corresponded to Thr-286 (cycle 10) being the predominant site of threonine phosphorylation by p34cdc2 (Fig. 4A ). However, the phosphate level did not return to the baseline, suggesting that Thr-292 was also phosphorylated. To test this hypothesis, the phosphorylated peptide was proteolytically cleaved with trypsin and subjected to HVE/TLC (Fig.  4B, inset) . Two novel phosphopeptides were identified and subjected to sequence analysis for the release of 32P-labeled residues. Phosphopeptide 2 contained phosphorylated Thr-286, and phosphopeptide 3 contained phosphorylated Thr-292 (Fig. 4B) . The amino acid sequence of phosphopeptide 3 was confirmed by repetitive Edman degradation and an analysis of amino acid residues at each cycle independently of the phosphopeptide sequence (data not shown).
Phosphopeptide mapping of MKK1. p34CdK2_phosphorylated MKK1 (Fig. 1, lane 1) was digested with thermolysin and subjected to two-dimensional phosphopeptide mapping (Fig.  5A) . Two predominant phosphopeptides, one major and one minor (labeled ot and 3, respectively), were observed. Several additional minor phosphopeptides, possibly reflecting incomplete digestion, were also identified.
Phosphopeptide mapping was also performed on the thermolysin-treated synthetic MKK1 peptide phosphorylated by p34cdc2 (Fig. 5B) . Two phosphopeptides (labeled 1 and 2) were identified. Both migrated, with respect to the origin, in posi-B. 
C.
Chrom. tions similar to those of phosphopeptides a and 3 identified in Fig. 5A . To determine the relationship of phosphopeptides 1 and 2 to phosphopeptides a and 3, samples identical to those in Fig. 5A and B were mixed and subjected to phosphopeptide mapping (Fig. 5C ). Phosphopeptides 1 and 2 comigrated with phosphopeptides a and ,B, respectively. Thus, MKK1 appears to be phosphorylated by p34c c2 on the site corresponding to the synthetic MKK1 peptide. Since MKK1 is phosphorylated on both Thr-286 and Thr-292, phosphopeptide a is likely to contain both of these sites phosphorylated, while phosphopeptide , may be a singly phosphorylated form.
Identification of MKK in HeLa cell extracts. MKK1-specific antisera were raised in rabbits against the above-mentioned synthetic MKK1 peptide, and the corresponding antibodies were affinity purified for use in identifying MKK1. To determine the antibody specificity, recombinant MKK1 and MKK2 were subjected to SDS-PAGE and immunoblotted with the Rl antibody (Fig. 6 ). In addition, identical samples were immunoblotted with an antibody to STE7 (see Materials and Methods), a yeast MKK homolog (13) . The STE7 antibody reacts with an epitope that is conserved among known MKKs. The STE7 antibody reacted with both MKK1 and MKK2 (left panel), but only MKK1 was detected by the Rl antibody (right panel).
To expand our studies of MKK1 inactivation in vivo, it was necessary to identify and precipitate the protein from cell lysates so that its phosphorylation state could be determined. Therefore, we used the Rl antibody to immunoblot HeLa cell lysates (Fig. 7) . Ri reacted with a 45-kDa protein doublet in lysates from HeLa (fourth lane, right arrow), suggesting that the lower form may be cell cycle regulated. Additional proteins of higher molecular masses were identified by Rl in both the immunoprecipitation lane (second lane) and the SDS cell lysate lanes (third and fourth lanes), but the identities of these proteins are currently unknown.
Phosphopeptide mapping of MKK labeled in vivo. In continuing our efforts to identify the in vivo phosphorylation sites of MKK1, both 32P-labeled phosphoproteins identified above were eluted separately from the polyacrylamide gel, digested with thermolysin, and subjected to HVE/TLC (Fig. 8) . Two phosphopeptides that were identified for the lower phosphoprotein (Fig. 8A , labeled y and 8) did not comigrate with the p34cdc2-phosphorylated thermolysin-treated synthetic peptide (Fig. 8B, labeled 1 phopeptides were identified for the upper phosphoprotein (Fig. 8C, labeled a-, y, and 8) ; the cx phosphopeptide comigrated with the phosphorylated MKK1 peptide (Fig. 8D These findings are important to MKK1 regulation and to the regulation of the entire p42naPk cascade because they imply that a ne ative feedback mechanism controls MKK1 activity. The p34c 2-catalyzed phosphorylation of MKK1 in vitro overrides the activating phosphorylation that can be accomplished by Raf (10, 20, 23 (44) , and cloned Xenopus oocyte MKK does not contain these phosphorylation sites (22) . Thus, p42maPk feedback mechanisms acting through MKK may depend upon the MKK isoforms present in the stimulated cell.
The demonstration in this report that MKK1 can be phosphorylated and inactivated in vitro by p34cdc2 and the identification of the same MKK phosphorylations in vivo provide evidence that p34cdc2 kinase could modulate the activity of extracellular signal-regulated protein kinases. Existing paradigms of growth factor action strive to describe the mechanisms by which these external signals stimulate cell division. Our data expand this paradigm by suggesting that cell division negatively affects the growth factor-activated protein kinase cascade.
